Serotiny
About:
Serotiny is an AI-based platform that invents multi-domain therapeutic proteins for CAR T-cell therapies.
Website: https://serotiny.bio/
Twitter/X: serotinybio
Top Investors: National Science Foundation, 8VC, +ND Capital
Description:
Serotiny is an AI-based platform that invents multi-domain therapeutic proteins for CAR T-cell therapies. It also helps in developing multi-domain proteins for cell therapies for the treatment of cancer and a genetic disorder.
Total Funding Amount:
$3.15M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
San Francisco, California, United States
Founded Date:
2014-01-01
Contact Email:
info(AT)serotiny.bio
Founders:
Colin Farlow, Justin Farlow
Number of Employees:
11-50
Last Funding Date:
2018-07-10
IPO Status:
Private
Industries:
© 2025 bioDAO.ai